ABSTRACT
Background A T cell positive and B cell negative (T+B-) flow cytometry crossmatch (FCXM) result remains a conundrum since HLA-class I antigens are expressed on both T and B cells. We investigated the frequency, HLA specificity of the antibodies and mechanisms for the T+B- FCXM result.
Methods We analyzed 3073 clinical FCXM tests performed in an American Society of Histocompatibility and Immunogenetics accredited histocompatibility laboratory. The sera associated with the T+B- FCXM were also tested for donor HLA IgG antibodies using LABScreen™ single antigen assays.
Results Among the 3073 FCXM tests, 1963 were T-B-, 811 were T-B+, 274 were T+B+, and 25 were T+B-. IgG antibodies directed at donor HLA-A, B, or Cw locus determined antigens (DSA) were identified in all 25 sera and the summed mean fluorescence intensity (MFI) of DSA ranged from 212 to 53,187. Correlational analyses identified a significant association between the summed MFI of class I DSA, and the median channel fluorescence (MCF) of T cells treated with the recipient serum (Spearman rank correlation, rs=0.34, P=0.05) but not with the MCF of B cells (rs=0.23, P=0.24). We identified that differential binding of anti-HLA antibodies to T cells and B cells and the B cell channel shift threshold used to classify a B cell FCXM are potential contributors to a T+B- FCXM result.
Conclusions Our analysis of 3073 FCXM, in addition to demonstrating that HLA antibodies directed at HLA-A, B or Cw locus are associated with a T+B- result, identified mechanisms for the surprising T+B- FCXM result.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Weill Cornell Medicine Institutional Review Board
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Authorship P.P., V.K.S, and M.S. designed research
P.P., V.K.S, R.F., and A.M. performed research
T.M., V.K.S., R.F., A.M., D.D, T.M., and M.S. analyzed data
P.P. and M.S. wrote the paper
Disclosure Manikkam Suthanthiran has a Consultancy Agreement with CareDx, Inc. Brisbane, CA and with Sparks Therapeutics, Philadelphia, PA. The other authors of this manuscript declare no conflicts of interest. The other authors have no disclosures.
Funding None
Data Availability
Not applicable
ABBREVIATIONS
- ACD
- Acid Citrate Dextrose
- B cell
- B lymphocyte
- CD
- cluster of differentiation
- CDC-XM
- complement dependent cytotoxicity crossmatch
- CS
- channel shift
- DSA
- donor specific antibody
- EDTA
- Ethylenediaminetetraacetic acid
- F(ab’)2
- fragment antigen-binding
- Fc
- fragement crystallizable
- FCXM
- flow cytometry crossmatch
- FITC
- Fluorescein isothiocyanate
- FSC
- forward scatter
- HLA
- human leukocyte antigen
- IgG
- Immunoglobulin G
- IQR
- interquartile range
- LSA
- Luminex single antigen
- mAb
- monoclonal antbody
- MCF
- median channel fluorescence
- MFI
- mean fluorescence intensity
- NCS
- negative control serum
- PBMC
- peripheral blood mononuclear cells
- PBS
- phosphate buffered saline
- PCS
- positive control serum
- PE
- Phycoerythrin
- PerCP
- Peridinin-Chlorophyll-Protein
- RS
- recipient serum
- SSC
- side scatter
- T cell
- T lymphocyte